Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic.
COVID‐19
Crohn's disease
inflammatory bowel diseases
ulcerative colitis
Journal
JGH open : an open access journal of gastroenterology and hepatology
ISSN: 2397-9070
Titre abrégé: JGH Open
Pays: Australia
ID NLM: 101730833
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
received:
07
05
2020
accepted:
09
05
2020
entrez:
10
6
2020
pubmed:
10
6
2020
medline:
10
6
2020
Statut:
epublish
Résumé
The COVID-19 pandemic, secondary to SARS-CoV-2, has resulted in high mortality and morbidity worldwide. As inflammatory bowel disease (IBD) is a chronic disease, and most patients are on long-term immunosuppressive agents, there is understandable concern, particularly in terms of therapy. In view of this, experts in IBD across the Asia Pacific region were invited to put together recommendations based on their experience and the currently available data. In general, most IBD therapies (with a few exceptions) can be continued safely, and the general consensus is that maintaining disease control should remain the main principle of management. In addition, social distancing measures and the appropriate use of personal protective equipment should be strictly adhered to. During the current pandemic, face-to-face clinic follow ups and non-urgent procedures should be kept to a minimum.
Identifiants
pubmed: 32514431
doi: 10.1002/jgh3.12362
pii: JGH312362
pmc: PMC7273734
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
320-323Informations de copyright
© 2020 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Références
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Lancet Gastroenterol Hepatol. 2020 May;5(5):425-427
pubmed: 32171057
Lancet Rheumatol. 2020 May;2(5):e255-e256
pubmed: 32368737
Acta Paediatr. 2020 Jun;109(6):1088-1095
pubmed: 32202343
Lancet Gastroenterol Hepatol. 2020 Apr 22;:
pubmed: 32333844
Lancet. 2020 May 2;395(10234):1407-1409
pubmed: 32278362
J Med Virol. 2020 Mar 31;:
pubmed: 32232986
Nat Med. 2020 May;26(5):676-680
pubmed: 32371934
J Crohns Colitis. 2020 Mar 24;:
pubmed: 32211765
Gut. 2019 Jan;68(1):40-48
pubmed: 29247068
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Infect Control Hosp Epidemiol. 2020 Jun;41(6):753-754
pubmed: 32188528
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Am J Gastroenterol. 2020 May;115(5):766-773
pubmed: 32287140
Gastroenterology. 2020 Apr 6;:
pubmed: 32272113
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
J Med Virol. 2020 Jul;92(7):833-840
pubmed: 32243607
Gut. 2020 Jul;69(7):1335-1342
pubmed: 32303609
Gastroenterology. 2020 May;158(6):1831-1833.e3
pubmed: 32142773
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Gastroenterology. 2020 Apr 3;:
pubmed: 32251668
mBio. 2020 Mar 26;11(2):
pubmed: 32217609
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
Gut. 2020 Jun;69(6):1002-1009
pubmed: 32213556
Lancet Gastroenterol Hepatol. 2020 May 12;:
pubmed: 32405603
Chest. 2020 Apr 15;:
pubmed: 32304772
JAMA. 2020 Feb 7;:
pubmed: 32031570
J Infect. 2020 Apr 23;:
pubmed: 32333918
Gut. 2020 Jul;69(7):1213-1217
pubmed: 32354990
Gut. 2020 Jun;69(6):991-996
pubmed: 32241897
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1372-1379
pubmed: 32242738
Clin Immunol. 2020 May;214:108393
pubmed: 32222466